Suven Pharmaceuticals Limited has informed the Exchange about update on Merger
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suven Pharmaceuticals Limited has submitted an update on its ongoing merger to the stock exchange. The filing relates to the previously announced merger scheme involving Suven Pharmaceuticals and Cohance Lifesciences. No specific financial details, ratios, or timeline have been disclosed in this particular update. Shareholders are advised to refer to the company's earlier detailed disclosures for the structure and terms of the transaction.
This is a procedural update on a previously known corporate action and is unlikely to cause any immediate stock price movement. Investors should watch for further filings that may include merger ratio details, NCLT hearing dates, or record dates.